Triton BioSystems is focused on discovering and developing non-invasive therapeutics to treat late-stage cancers, including breast, head and neck, lung, colon, ovarian, pancreatic, and prostate. Their main product, the Targeted Nano-Therapeutics system, is currently in the pre-clinical stage. This system shows promise in providing targeted treatment for various types of cancer, offering a potential alternative to invasive procedures.